GO Term |
GO Name |
Enriched Genes |
Log10 Adjusted P-value |
[BP] GO:0065008 |
regulation of biological quality
|
ACHE, AKR1B1, APEX1, AURKB, AXL, CA12, CA2, CA7, CYP19A1, CYP1A1, CYP1B1, CYP3A4, DRD1, DRD2, DRD3, DRD4, F3, FABP3, FABP4, FLT3, GLRA1, GRIA2, GRIA4, GRIK5, GRM1, GRM5, HSD17B1, HSD17B2, KDR, MET, PPARA, PPARD, PRKCA, SLC1A1, SLC6A2, SLC6A3, SRC, XDH |
10.5408 |
[BP] GO:0010033 |
response to organic substance
|
AKR1B1, APEX1, AXL, CA2, CSNK2A1, CYP1A1, CYP1A2, CYP1B1, DRD1, DRD2, DRD3, DRD4, FABP3, FABP4, FLT3, GLRA1, GRIK5, GRM5, HSD17B2, IGF1R, KDR, MMP2, PPARA, PPARD, PRKCA, RORC, SLC6A3, SRC, TYR |
9.24523 |
[BP] GO:1901700 |
response to oxygen-containing compound
|
AKR1B1, APEX1, AXL, CSNK2A1, CYP1A1, CYP1A2, CYP1B1, DRD1, DRD2, DRD3, FABP3, GLRA1, GRIK5, GRM5, HSD17B2, IGF1R, MMP2, MMP9, PPARA, PPARD, RORC, SLC6A3, SRC, TYR |
9.15944 |
[BP] GO:0042221 |
response to chemical
|
AKR1B1, APEX1, AXL, CA2, CSNK2A1, CYP1A1, CYP1A2, CYP1B1, DRD1, DRD2, DRD3, DRD4, FABP3, FABP4, FLT3, GLRA1, GRIK5, GRM5, HSD17B2, IGF1R, KDR, MMP2, MMP9, PPARA, PPARD, PRKCA, RORC, SLC6A2, SLC6A3, SRC, TYR |
8.72026 |
[BP] GO:0007215 |
None
|
GRIA2, GRIA4, GRIK5, GRM1, GRM3, GRM5, GRM8 |
6.96067 |
[BP] GO:0048518 |
positive regulation of biological process
|
ACHE, AKR1B1, APEX1, AURKB, AXL, CA2, CA7, CDC25B, CSNK2A1, CYP19A1, CYP1A1, CYP1B1, DRD1, DRD2, DRD3, DRD4, F3, FABP3, FABP4, FLT3, GLRA1, GRIK5, GRM1, GRM5, IGF1R, KDR, MET, MMP1, MMP12, MMP2, MMP9, PIM1, PPARA, PPARD, PRKCA, PTPN1, RORC, SLC1A1, SLC6A3, SRC, TOP2A, XDH |
6.96067 |
[BP] GO:0010035 |
response to inorganic substance
|
AKR1B1, APEX1, AXL, CA2, CYP1A1, CYP1A2, CYP1B1, DRD2, FABP4, GLRA1, KDR, MMP9, SLC6A3, SRC |
6.81958 |
[BP] GO:0050804 |
modulation of chemical synaptic transmission
|
ACHE, CA2, CA7, DRD1, DRD2, DRD3, DRD4, GRIK5, GRM1, GRM3, GRM5, GRM8 |
6.81958 |
[BP] GO:0099177 |
regulation of trans-synaptic signaling
|
ACHE, CA2, CA7, DRD1, DRD2, DRD3, DRD4, GRIK5, GRM1, GRM3, GRM5, GRM8 |
6.81958 |
[BP] GO:0010647 |
positive regulation of cell communication
|
AKR1B1, AXL, CA2, CA7, CSNK2A1, CYP19A1, CYP1B1, DRD1, DRD2, DRD3, DRD4, F3, FLT3, GRM1, KDR, MET, MMP12, MMP9, PPARD, PRKCA, PTPN1, SRC, XDH |
6.55806 |
[BP] GO:0009636 |
response to toxic substance
|
AKR1B1, APEX1, AXL, CYP1A1, CYP1B1, DRD1, DRD2, DRD3, DRD4, GLRA1, KDR, SLC6A3, SRC |
6.55806 |
[BP] GO:0023056 |
positive regulation of signaling
|
AKR1B1, AXL, CA2, CA7, CSNK2A1, CYP19A1, CYP1B1, DRD1, DRD2, DRD3, DRD4, F3, FLT3, GRM1, KDR, MET, MMP12, MMP9, PPARD, PRKCA, PTPN1, SRC, XDH |
6.54395 |
[BP] GO:1901615 |
organic hydroxy compound metabolic process
|
AKR1B1, AKR1B10, CYP19A1, CYP1A1, CYP1B1, CYP3A4, DRD1, DRD2, DRD3, DRD4, PPARD, SLC6A3, TYR |
6.46513 |
[BP] GO:0015711 |
organic anion transport
|
CA1, CA12, CA14, CA2, CA4, CA7, DRD2, DRD3, DRD4, FABP3, PPARA, PPARD, SLC1A1 |
6.43334 |
[BP] GO:0032501 |
multicellular organismal process
|
AKR1B1, AKR1B10, ALOX5, AXL, CYP19A1, CYP1A2, CYP1B1, DRD1, DRD2, DRD3, DRD4, F3, FABP4, GLRA1, GRM1, GRM5, GRM8, HSD17B2, IGF1R, MET, MMP1, MMP12, MMP2, MMP9, PIM1, PPARA, PPARD, RORC, SLC6A2, SLC6A3, SRC, TYR |
6.28614 |
[BP] GO:0010243 |
response to organonitrogen compound
|
AKR1B1, APEX1, DRD1, DRD2, DRD3, DRD4, FABP3, FLT3, GLRA1, GRM5, IGF1R, MMP2, PPARA, SLC6A3, SRC, TYR |
6.13835 |
[BP] GO:0006820 |
anion transport
|
CA1, CA12, CA14, CA2, CA4, CA7, DRD2, DRD3, DRD4, FABP3, GLRA1, PPARA, PPARD, SLC1A1 |
6.13733 |
[BP] GO:0006811 |
None
|
CA1, CA12, CA14, CA2, CA4, CA7, DRD1, DRD2, DRD3, DRD4, FABP3, GLRA1, GRIA2, GRIA4, GRIK5, PPARA, PPARD, SLC1A1, SLC6A2, SLC6A3 |
6.09784 |
[BP] GO:0048522 |
positive regulation of cellular process
|
ACHE, AKR1B1, APEX1, AURKB, AXL, CA2, CA7, CDC25B, CSNK2A1, CYP19A1, CYP1A1, CYP1B1, DRD1, DRD2, DRD3, DRD4, F3, FABP3, FLT3, GRIK5, GRM1, GRM5, IGF1R, KDR, MET, MMP1, MMP12, MMP2, MMP9, PIM1, PPARA, PPARD, PRKCA, PTPN1, RORC, SRC, TOP2A, XDH |
6.09784 |
[BP] GO:0007268 |
None
|
DRD1, DRD2, DRD3, GLRA1, GRIA2, GRIK5, GRM1, GRM3, GRM5, SLC1A1, SLC6A2 |
6.03859 |
[BP] GO:0098916 |
None
|
DRD1, DRD2, DRD3, GLRA1, GRIA2, GRIK5, GRM1, GRM3, GRM5, SLC1A1, SLC6A2 |
6.03859 |
[BP] GO:0010941 |
regulation of cell death
|
AKR1B1, APEX1, AURKB, AXL, CSNK2A1, CYP1B1, F3, FLT3, GLO1, GRIK5, IGF1R, KDR, MET, MMP9, PIM1, PPARA, PPARD, PRKCA, PTPN1, SRC, TOP2A, XDH |
6.024 |
[BP] GO:0010646 |
regulation of cell communication
|
ACHE, AKR1B1, AURKB, AXL, CA2, CA7, CSNK2A1, CYP19A1, CYP1B1, DRD1, DRD2, DRD3, DRD4, F3, FLT3, GLRA1, GRIK5, GRM1, GRM3, GRM5, GRM8, IGF1R, KDR, MET, MMP12, MMP9, PPARD, PRKCA, PTPN1, SRC, XDH |
5.98029 |
[BP] GO:0099536 |
None
|
DRD1, DRD2, DRD3, GLRA1, GRIA2, GRIK5, GRM1, GRM3, GRM5, SLC1A1, SLC6A2 |
5.98029 |
[BP] GO:0099537 |
None
|
DRD1, DRD2, DRD3, GLRA1, GRIA2, GRIK5, GRM1, GRM3, GRM5, SLC1A1, SLC6A2 |
5.98029 |
[BP] GO:0050896 |
response to stimulus
|
ACHE, ADORA3, AKR1B1, APEX1, AURKB, AXL, CA2, CSNK2A1, CYP1A1, CYP1A2, CYP1B1, DRD1, DRD2, DRD3, DRD4, F3, FABP3, FABP4, FLT3, GLRA1, GRIK5, GRM1, GRM5, HSD17B2, IGF1R, KDR, MMP12, MMP2, MMP9, PPARA, PPARD, PRKCA, PTPN1, RORC, SLC6A2, SLC6A3, SRC, TOP2A, TYR |
5.97935 |
[BP] GO:1900543 |
None
|
DRD2, DRD3, DRD4, GRM3, GRM8, PPARA, PRKCA |
5.91884 |
[BP] GO:0023051 |
regulation of signaling
|
ACHE, AKR1B1, AURKB, AXL, CA2, CA7, CSNK2A1, CYP19A1, CYP1B1, DRD1, DRD2, DRD3, DRD4, F3, FLT3, GLRA1, GRIK5, GRM1, GRM3, GRM5, GRM8, IGF1R, KDR, MET, MMP12, MMP9, PPARD, PRKCA, PTPN1, SRC, XDH |
5.90809 |
[BP] GO:0043067 |
regulation of programmed cell death
|
AKR1B1, APEX1, AURKB, AXL, CSNK2A1, CYP1B1, F3, FLT3, GLO1, GRIK5, IGF1R, KDR, MET, MMP9, PIM1, PPARD, PRKCA, PTPN1, SRC, TOP2A, XDH |
5.90687 |
[BP] GO:0045980 |
None
|
DRD2, DRD3, DRD4, GRM3, GRM8, PPARA, PRKCA |
5.90687 |
[BP] GO:1901698 |
response to nitrogen compound
|
AKR1B1, APEX1, DRD1, DRD2, DRD3, DRD4, FABP3, FLT3, GLRA1, GRM5, IGF1R, MMP2, PPARA, SLC6A3, SRC, TYR |
5.88533 |
[BP] GO:0007193 |
None
|
DRD2, DRD3, DRD4, GRM1, GRM3, GRM5, GRM8 |
5.78118 |
[BP] GO:0006584 |
None
|
AKR1B1, DRD1, DRD2, DRD3, DRD4, SLC6A3 |
5.7728 |
[BP] GO:0009712 |
None
|
AKR1B1, DRD1, DRD2, DRD3, DRD4, SLC6A3 |
5.7728 |
[BP] GO:0014070 |
response to organic cyclic compound
|
APEX1, CA2, CSNK2A1, CYP1A1, CYP1A2, CYP1B1, DRD1, DRD2, DRD3, DRD4, FLT3, RORC, SLC6A3, SRC, TYR |
5.75657 |
[BP] GO:0008202 |
steroid metabolic process
|
AKR1B1, AKR1B10, CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP3A4, HSD17B1, HSD17B2, PPARD |
5.75546 |
[BP] GO:0018958 |
None
|
AKR1B1, DRD1, DRD2, DRD3, DRD4, SLC6A3, TYR |
5.75157 |
[BP] GO:0030818 |
None
|
DRD2, DRD3, DRD4, GRM3, GRM8, PRKCA |
5.75157 |
[BP] GO:0015701 |
bicarbonate transport
|
CA1, CA12, CA14, CA2, CA4, CA7 |
5.75157 |
[BP] GO:0097164 |
None
|
ACHE, AKR1B1, AKR1B10, CSNK2A1, DRD1, DRD2, DRD3, DRD4, SLC6A3 |
5.73872 |
[BP] GO:0042493 |
response to drug
|
AKR1B1, APEX1, AXL, CYP1A1, CYP1B1, DRD1, DRD2, DRD3, DRD4, FABP3, GLRA1, KDR, SLC6A2, SLC6A3, SRC |
5.7248 |
[BP] GO:0001505 |
regulation of neurotransmitter levels
|
ACHE, CYP1B1, DRD1, DRD2, DRD3, DRD4, GRIK5, SLC1A1, SLC6A2, SLC6A3 |
5.67577 |
[BP] GO:0051940 |
None
|
DRD1, DRD2, DRD3, DRD4 |
5.67577 |
[BP] GO:0051584 |
None
|
DRD1, DRD2, DRD3, DRD4 |
5.67577 |
[BP] GO:0030803 |
None
|
DRD2, DRD3, DRD4, GRM3, GRM8, PRKCA |
5.67577 |
[BP] GO:0030815 |
None
|
DRD2, DRD3, DRD4, GRM3, GRM8, PRKCA |
5.56761 |
[BP] GO:1900372 |
None
|
DRD2, DRD3, DRD4, GRM3, GRM8, PRKCA |
5.53245 |
[BP] GO:0030809 |
None
|
DRD2, DRD3, DRD4, GRM3, GRM8, PRKCA |
5.53245 |
[BP] GO:0030800 |
None
|
DRD2, DRD3, DRD4, GRM3, GRM8, PRKCA |
5.48461 |
[BP] GO:0007196 |
None
|
GRM1, GRM3, GRM5, GRM8 |
5.46802 |
[BP] GO:0019748 |
secondary metabolic process
|
AKR1B1, AKR1B10, CYP1A1, CYP1A2, CYP1B1, TYR |
5.44425 |
[BP] GO:0042981 |
regulation of apoptotic process
|
AKR1B1, APEX1, AURKB, AXL, CSNK2A1, CYP1B1, F3, FLT3, GLO1, GRIK5, IGF1R, KDR, MMP9, PIM1, PPARD, PRKCA, PTPN1, SRC, TOP2A, XDH |
5.39574 |
[BP] GO:0006629 |
lipid metabolic process
|
ACHE, AKR1B1, AKR1B10, ALOX5, CSNK2A1, CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP3A4, DRD2, FABP3, FABP4, HSD17B1, HSD17B2, MET, PPARA, PPARD |
5.34684 |
[BP] GO:0032879 |
regulation of localization
|
ACHE, ADORA3, APEX1, AXL, CA2, CA7, CSNK2A1, CYP19A1, CYP1B1, DRD1, DRD2, DRD3, DRD4, F3, GRIK5, GRM5, IGF1R, KDR, MET, MMP12, MMP9, PPARA, PPARD, PRKCA, PTPN1, SRC |
5.27033 |
[BP] GO:0030817 |
None
|
DRD1, DRD2, DRD3, DRD4, GRM3, GRM8, PRKCA |
5.2029 |
[BP] GO:0042417 |
None
|
DRD1, DRD2, DRD3, DRD4, SLC6A3 |
5.18699 |
[BP] GO:0007188 |
None
|
DRD1, DRD2, DRD3, DRD4, GRM1, GRM3, GRM5, GRM8 |
5.1323 |
[BP] GO:0051966 |
regulation of synaptic transmission, glutamatergic
|
DRD1, DRD2, GRM1, GRM3, GRM5, GRM8 |
5.1303 |
[BP] GO:0034754 |
cellular hormone metabolic process
|
AKR1B1, CYP19A1, CYP1A1, CYP1B1, CYP3A4, HSD17B1, HSD17B2 |
4.95299 |
[BP] GO:0007194 |
None
|
DRD2, DRD3, DRD4, GRM3, PRKCA |
4.92304 |
[BP] GO:0042127 |
regulation of cell proliferation
|
ADORA3, AKR1B1, CDC25B, CSNK2A1, CYP1B1, DRD2, DRD3, F3, FABP3, FLT3, IGF1R, KDR, MMP12, MMP2, MMP9, PIM1, PPARD, PRKCA, SRC, XDH |
4.8883 |
[BP] GO:1901701 |
cellular response to oxygen-containing compound
|
AKR1B1, APEX1, AXL, CYP1B1, DRD1, GLRA1, GRIK5, GRM5, IGF1R, MMP2, MMP9, PPARD, RORC, SRC |
4.85632 |
[BP] GO:0044092 |
negative regulation of molecular function
|
ADORA3, AURKB, CSNK2A1, CYP1B1, DRD2, DRD3, DRD4, FABP4, GRM3, IGF1R, MET, MMP9, PIM1, PPARA, PRKCA, PTPN1, SRC |
4.85361 |
[BP] GO:0008284 |
positive regulation of cell proliferation
|
AKR1B1, CDC25B, CSNK2A1, DRD2, DRD3, F3, FLT3, IGF1R, KDR, MMP12, MMP2, MMP9, PIM1, PPARD, PRKCA |
4.85284 |
[BP] GO:0060134 |
None
|
DRD1, DRD2, DRD3, SLC6A3 |
4.85108 |
[BP] GO:0015908 |
None
|
DRD2, DRD3, DRD4, FABP3, PPARA, PPARD |
4.84859 |
[BP] GO:0070887 |
cellular response to chemical stimulus
|
AKR1B1, APEX1, AXL, CYP1A1, CYP1A2, CYP1B1, DRD1, FABP4, FLT3, GLRA1, GRIK5, GRM5, IGF1R, KDR, MMP2, MMP9, PPARD, RORC, SRC |
4.84654 |
[BP] GO:0031280 |
None
|
DRD2, DRD3, DRD4, GRM3, PRKCA |
4.83796 |
[BP] GO:0040012 |
regulation of locomotion
|
ADORA3, APEX1, CYP19A1, CYP1B1, DRD1, DRD2, DRD3, F3, IGF1R, KDR, MET, MMP9, PPARD, PRKCA, SRC |
4.83796 |
[BP] GO:0017144 |
drug metabolic process
|
ACHE, AKR1B1, AKR1B10, CYP1A1, CYP1A2, CYP1B1, CYP3A4, DRD1, DRD2, DRD3, DRD4, SLC6A3 |
4.83042 |
[BP] GO:0030814 |
None
|
DRD1, DRD2, DRD3, DRD4, GRM3, GRM8, PRKCA |
4.80574 |
[BP] GO:0030334 |
regulation of cell migration
|
ADORA3, APEX1, CYP19A1, CYP1B1, DRD1, DRD2, F3, IGF1R, KDR, MET, MMP9, PPARD, PRKCA, SRC |
4.76955 |
[BP] GO:0007626 |
None
|
DRD1, DRD2, DRD3, DRD4, GLRA1, GRM1, GRM5, SLC6A3 |
4.76069 |
[BP] GO:0007216 |
None
|
GRM1, GRM3, GRM5, GRM8 |
4.75526 |
[BP] GO:0051580 |
None
|
DRD1, DRD2, DRD3, DRD4 |
4.75526 |
[BP] GO:0009967 |
positive regulation of signal transduction
|
AKR1B1, AXL, CSNK2A1, CYP1B1, DRD2, DRD3, DRD4, F3, FLT3, GRM1, KDR, MET, MMP12, MMP9, PPARD, PRKCA, PTPN1, SRC, XDH |
4.75526 |
[BP] GO:0030802 |
None
|
DRD1, DRD2, DRD3, DRD4, GRM3, GRM8, PRKCA |
4.75526 |
[BP] GO:0006730 |
one-carbon metabolic process
|
CA1, CA12, CA2, CA4, CA7 |
4.75175 |
[BP] GO:0051350 |
None
|
DRD2, DRD3, DRD4, GRM3, PRKCA |
4.75175 |
[BP] GO:0042592 |
homeostatic process
|
AKR1B1, APEX1, AXL, CA12, CA2, CA7, DRD1, DRD2, DRD3, DRD4, FABP3, FABP4, FLT3, GRIK5, GRM1, GRM5, MET, SRC |
4.72906 |
[BP] GO:0007187 |
None
|
DRD1, DRD2, DRD3, DRD4, GRM1, GRM3, GRM5, GRM8 |
4.72031 |
[BP] GO:0042445 |
hormone metabolic process
|
ACHE, AKR1B1, CYP19A1, CYP1A1, CYP1B1, CYP3A4, HSD17B1, HSD17B2 |
4.6959 |
[BP] GO:0071310 |
cellular response to organic substance
|
AKR1B1, APEX1, AXL, CYP1A1, CYP1B1, DRD1, FABP4, FLT3, GLRA1, GRIK5, GRM5, IGF1R, KDR, MMP2, PPARD, RORC, SRC |
4.68657 |
[BP] GO:0044281 |
small molecule metabolic process
|
AKR1B1, AKR1B10, ALOX5, CA1, CA12, CA2, CA4, CA7, CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP3A4, FABP3, GLO1, PIM1, PPARA, PPARD, TYR, XDH |
4.66143 |
[BP] GO:0019220 |
regulation of phosphate metabolic process
|
CDC25B, DRD1, DRD2, DRD3, DRD4, FABP3, FABP4, FLT3, GRM1, GRM3, GRM5, GRM8, IGF1R, KDR, MMP9, PPARA, PRKCA, PTPN1, SRC, XDH |
4.58011 |
[BP] GO:0060078 |
None
|
DRD4, GLRA1, GRIA2, GRIA4, GRIK5, GRM5 |
4.58011 |
[BP] GO:1900371 |
None
|
DRD1, DRD2, DRD3, DRD4, GRM3, GRM8, PRKCA |
4.56588 |
[BP] GO:0032225 |
None
|
DRD1, DRD2, DRD3, DRD4 |
4.55844 |
[BP] GO:0060548 |
negative regulation of cell death
|
AKR1B1, AURKB, AXL, CSNK2A1, GLO1, IGF1R, KDR, MET, MMP9, PIM1, PPARA, PPARD, PRKCA, PTPN1, SRC |
4.55844 |
[BP] GO:0030808 |
None
|
DRD1, DRD2, DRD3, DRD4, GRM3, GRM8, PRKCA |
4.55397 |
[BP] GO:0051174 |
regulation of phosphorus metabolic process
|
CDC25B, DRD1, DRD2, DRD3, DRD4, FABP3, FABP4, FLT3, GRM1, GRM3, GRM5, GRM8, IGF1R, KDR, MMP9, PPARA, PRKCA, PTPN1, SRC, XDH |
4.54378 |
[BP] GO:2000145 |
regulation of cell motility
|
ADORA3, APEX1, CYP19A1, CYP1B1, DRD1, DRD2, F3, IGF1R, KDR, MET, MMP9, PPARD, PRKCA, SRC |
4.52431 |
[BP] GO:1902533 |
positive regulation of intracellular signal transduction
|
AKR1B1, AXL, CYP1B1, DRD2, DRD4, F3, FLT3, GRM1, KDR, MET, PPARD, PRKCA, PTPN1, SRC, XDH |
4.43138 |
[BP] GO:0048511 |
rhythmic process
|
AXL, CSNK2A1, DRD2, DRD3, DRD4, PPARA, RORC, SRC, TOP2A |
4.4225 |
[BP] GO:0007166 |
cell surface receptor signaling pathway
|
ADORA3, AXL, CA1, CSNK2A1, DRD2, F3, FLT3, GRIA2, GRIA4, GRIK5, GRM1, GRM3, GRM5, GRM8, IGF1R, KDR, MET, MMP2, MMP9, PRKCA, PTPN1, SRC |
4.40564 |
[BP] GO:0048523 |
negative regulation of cellular process
|
ACHE, ADORA3, AKR1B1, APEX1, AURKB, AXL, CSNK2A1, CYP19A1, CYP1B1, DRD1, DRD2, DRD3, DRD4, FABP3, FABP4, GLO1, GLRA1, GRM3, GRM8, IGF1R, KDR, MET, MMP12, MMP9, PIM1, PPARA, PPARD, PRKCA, PTPN1, RORC, SRC, TOP2A, XDH |
4.35382 |
[BP] GO:0045761 |
None
|
DRD2, DRD3, DRD4, GRM3, PRKCA |
4.33977 |
[BP] GO:0030799 |
None
|
DRD1, DRD2, DRD3, DRD4, GRM3, GRM8, PRKCA |
4.33037 |
[BP] GO:1902531 |
regulation of intracellular signal transduction
|
AKR1B1, AURKB, AXL, CSNK2A1, CYP1B1, DRD2, DRD3, DRD4, F3, FLT3, GRM1, IGF1R, KDR, MET, MMP9, PPARD, PRKCA, PTPN1, SRC, XDH |
4.32032 |
[BP] GO:0043069 |
negative regulation of programmed cell death
|
AKR1B1, AURKB, AXL, CSNK2A1, GLO1, IGF1R, KDR, MET, MMP9, PIM1, PPARD, PRKCA, PTPN1, SRC |
4.27525 |
[BP] GO:0065007 |
biological regulation
|
ACHE, ADORA3, AKR1B1, APEX1, AURKB, AXL, CA1, CA12, CA2, CA7, CDC25B, CSNK2A1, CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP3A4, DRD1, DRD2, DRD3, DRD4, F3, FABP3, FABP4, FLT3, GLO1, GLRA1, GRIA2, GRIA4, GRIK5, GRM1, GRM3, GRM5, GRM8, HSD17B1, HSD17B2, IGF1R, KDR, MET, MMP1, MMP12, MMP2, MMP9, PIM1, PPARA, PPARD, PRKCA, PTPN1, RORC, SLC1A1, SLC6A2, SLC6A3, SRC, TOP2A, XDH |
4.25684 |
[BP] GO:0051716 |
cellular response to stimulus
|
AKR1B1, APEX1, AURKB, AXL, CA2, CYP1A1, CYP1A2, CYP1B1, DRD1, FABP4, FLT3, GLRA1, GRIK5, GRM1, GRM5, IGF1R, KDR, MMP2, MMP9, PPARD, PTPN1, RORC, SRC, TOP2A |
4.20194 |
[BP] GO:0048148 |
None
|
DRD1, DRD2, DRD3, DRD4 |
4.20165 |
[BP] GO:0010817 |
regulation of hormone levels
|
ACHE, AKR1B1, CYP19A1, CYP1A1, CYP1B1, CYP3A4, DRD2, HSD17B1, HSD17B2, PPARD, PRKCA |
4.18869 |
[BP] GO:0051270 |
regulation of cellular component movement
|
ADORA3, APEX1, CYP19A1, CYP1B1, DRD1, DRD2, F3, IGF1R, KDR, MET, MMP9, PPARD, PRKCA, SRC |
4.14292 |
[BP] GO:0055114 |
oxidation-reduction process
|
AKR1B1, AKR1B10, ALOX5, APEX1, CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP3A4, HSD17B1, HSD17B2, PPARD, TYR, XDH |
4.1344 |
[BP] GO:0042752 |
None
|
DRD2, DRD3, DRD4, PPARA, RORC, TOP2A |
4.04316 |
[BP] GO:1900542 |
None
|
DRD1, DRD2, DRD3, DRD4, GRM3, GRM8, PPARA, PRKCA |
4.02749 |
[BP] GO:0032101 |
regulation of response to external stimulus
|
CYP19A1, DRD1, DRD2, DRD3, F3, FABP4, KDR, MET, MMP12, PPARA, PPARD, PRKCA, SLC6A3 |
4.00192 |
[BP] GO:0007165 |
signal transduction
|
ADORA3, AKR1B1, AXL, CA1, CA2, CSNK2A1, CYP1B1, DRD1, DRD2, DRD3, DRD4, F3, FLT3, GLRA1, GRIA2, GRIA4, GRIK5, GRM1, GRM3, GRM5, GRM8, IGF1R, KDR, MET, MMP2, MMP9, PIM1, PPARA, PPARD, PRKCA, PTPN1, RORC, SRC |
3.98491 |
[BP] GO:0006140 |
None
|
DRD1, DRD2, DRD3, DRD4, GRM3, GRM8, PPARA, PRKCA |
3.94292 |
[BP] GO:0048519 |
negative regulation of biological process
|
ACHE, ADORA3, AKR1B1, APEX1, AURKB, AXL, CSNK2A1, CYP19A1, CYP1B1, DRD1, DRD2, DRD3, DRD4, FABP3, FABP4, GLO1, GLRA1, GRM3, GRM8, IGF1R, KDR, MET, MMP12, MMP9, PIM1, PPARA, PPARD, PRKCA, PTPN1, RORC, SLC6A3, SRC, TOP2A, XDH |
3.92483 |
[BP] GO:0008210 |
estrogen metabolic process
|
CYP19A1, CYP1B1, HSD17B1, HSD17B2 |
3.90132 |
[BP] GO:0048878 |
chemical homeostasis
|
AKR1B1, CA12, CA2, CA7, DRD1, DRD2, DRD3, DRD4, FABP3, FABP4, GRIK5, GRM1, GRM5, MET |
3.88827 |
[BP] GO:0006721 |
terpenoid metabolic process
|
AKR1B10, CYP1A1, CYP1A2, CYP1B1, CYP3A4, PPARD |
3.84466 |
[BP] GO:0034614 |
cellular response to reactive oxygen species
|
AKR1B1, APEX1, AXL, CYP1B1, MMP9, SRC |
3.82377 |
[BP] GO:0044255 |
cellular lipid metabolic process
|
ACHE, AKR1B10, ALOX5, CSNK2A1, CYP1A1, CYP1A2, CYP1B1, CYP3A4, DRD2, FABP3, FABP4, MET, PPARA, PPARD |
3.78902 |
[BP] GO:0048584 |
positive regulation of response to stimulus
|
AKR1B1, AXL, CSNK2A1, CYP1B1, DRD2, DRD3, DRD4, F3, FABP4, FLT3, GRM1, KDR, MET, MMP12, MMP2, MMP9, PPARD, PRKCA, PTPN1, SRC, XDH |
3.78592 |
[BP] GO:0001975 |
None
|
DRD1, DRD2, DRD3, DRD4 |
3.77233 |
[BP] GO:0042446 |
hormone biosynthetic process
|
AKR1B1, CYP19A1, CYP3A4, HSD17B1, HSD17B2 |
3.75133 |
[BP] GO:0031279 |
None
|
DRD2, DRD3, DRD4, GRM3, PRKCA |
3.75133 |
[BP] GO:0051339 |
None
|
DRD2, DRD3, DRD4, GRM3, PRKCA |
3.72412 |
[BP] GO:0009719 |
response to endogenous stimulus
|
AKR1B1, APEX1, CA2, CSNK2A1, CYP1A2, DRD1, FABP3, FLT3, GLRA1, GRM5, IGF1R, MMP2, PPARA, SRC |
3.71124 |
[BP] GO:0009056 |
catabolic process
|
ACHE, AKR1B10, AURKB, CSNK2A1, CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP3A4, FABP3, FABP4, MMP1, MMP12, MMP2, MMP9, PPARD, SLC6A3, SRC, XDH |
3.67343 |
[BP] GO:0043066 |
negative regulation of apoptotic process
|
AKR1B1, AURKB, AXL, CSNK2A1, GLO1, IGF1R, KDR, MMP9, PIM1, PPARD, PRKCA, PTPN1, SRC |
3.62946 |
[BP] GO:0016042 |
lipid catabolic process
|
AKR1B10, CYP19A1, CYP1A2, CYP1B1, CYP3A4, FABP3, FABP4, PPARD |
3.6234 |
[BP] GO:0045936 |
None
|
DRD2, DRD3, DRD4, FABP4, GRM3, GRM8, IGF1R, PPARA, PRKCA, PTPN1, XDH |
3.6202 |
[BP] GO:0033993 |
response to lipid
|
AXL, CA2, CSNK2A1, CYP1A1, CYP1A2, FABP3, FLT3, HSD17B2, PPARD, RORC, SRC, TYR |
3.6202 |
[BP] GO:0010563 |
None
|
DRD2, DRD3, DRD4, FABP4, GRM3, GRM8, IGF1R, PPARA, PRKCA, PTPN1, XDH |
3.61752 |
[BP] GO:0097237 |
cellular response to toxic substance
|
AKR1B1, APEX1, AXL, CYP1B1, GLRA1, KDR |
3.60182 |
[BP] GO:0046777 |
protein autophosphorylation
|
AURKB, CSNK2A1, FLT3, IGF1R, KDR, PIM1, SRC |
3.5061 |
[BP] GO:0006720 |
isoprenoid metabolic process
|
AKR1B10, CYP1A1, CYP1A2, CYP1B1, CYP3A4, PPARD |
3.5061 |
[BP] GO:0035690 |
cellular response to drug
|
AKR1B1, APEX1, AXL, CYP1B1, DRD1, GLRA1, KDR, SRC |
3.50359 |
[BP] GO:0051173 |
positive regulation of nitrogen compound metabolic process
|
AURKB, CDC25B, CSNK2A1, DRD1, DRD2, DRD3, DRD4, F3, FLT3, GRM1, GRM5, IGF1R, KDR, MET, MMP12, MMP9, PPARA, PPARD, PRKCA, PTPN1, RORC, SRC, TOP2A, XDH |
3.45393 |
[BP] GO:0007169 |
transmembrane receptor protein tyrosine kinase signaling pathway
|
AXL, FLT3, IGF1R, KDR, MET, MMP2, MMP9, PRKCA, PTPN1, SRC |
3.45063 |
[BP] GO:0007267 |
None
|
DRD1, DRD2, DRD3, GLRA1, GRIA2, GRIK5, GRM1, GRM3, GRM5, SLC1A1, SLC6A2 |
3.41632 |
[BP] GO:0015718 |
None
|
DRD2, DRD3, DRD4, FABP3, PPARA, PPARD |
3.39253 |
[BP] GO:0007195 |
None
|
DRD2, DRD3, DRD4 |
3.39253 |
[BP] GO:2001225 |
regulation of chloride transport
|
CA2, CA7, GRM5 |
3.39253 |
[BP] GO:0097267 |
omega-hydroxylase P450 pathway
|
CYP1A1, CYP1A2, CYP1B1 |
3.39253 |
[BP] GO:0008152 |
metabolic process
|
ACHE, AKR1B1, AKR1B10, ALOX5, APEX1, AURKB, AXL, CA1, CA12, CA2, CA4, CA7, CDC25B, CSNK2A1, CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP3A4, DRD1, DRD2, DRD3, DRD4, F3, FABP3, FABP4, FLT3, GLO1, HSD17B1, HSD17B2, IGF1R, KDR, MET, MMP1, MMP12, MMP2, MMP9, PIM1, PPARA, PPARD, PRKCA, PTPN1, RORC, SLC6A3, SRC, TOP2A, TYR, XDH |
3.38919 |
[BP] GO:2000021 |
regulation of ion homeostasis
|
CA2, CA7, DRD1, DRD2, DRD3, KDR, SRC |
3.36653 |
[BP] GO:0042391 |
None
|
DRD1, DRD4, GLRA1, GRIA2, GRIA4, GRIK5, GRM5, KDR, SRC |
3.35625 |
[BP] GO:0051896 |
regulation of protein kinase B signaling
|
AXL, DRD2, DRD3, F3, MET, SRC, XDH |
3.33022 |
[BP] GO:0034776 |
None
|
DRD2, DRD3, DRD4 |
3.27397 |
[BP] GO:0030534 |
None
|
DRD1, DRD2, DRD3, DRD4, GLRA1, PPARA |
3.26643 |
[BP] GO:0007212 |
None
|
DRD1, DRD2, DRD3, DRD4 |
3.23624 |
[BP] GO:0032467 |
None
|
AURKB, CDC25B, DRD2, DRD3 |
3.23624 |
[BP] GO:0010562 |
positive regulation of phosphorus metabolic process
|
CDC25B, DRD1, DRD2, DRD4, FABP3, FLT3, GRM1, GRM5, KDR, MMP9, PRKCA, PTPN1, SRC, XDH |
3.21959 |
[BP] GO:0045937 |
positive regulation of phosphate metabolic process
|
CDC25B, DRD1, DRD2, DRD4, FABP3, FLT3, GRM1, GRM5, KDR, MMP9, PRKCA, PTPN1, SRC, XDH |
3.21959 |
[BP] GO:0031325 |
positive regulation of cellular metabolic process
|
AURKB, CDC25B, DRD1, DRD2, DRD3, DRD4, F3, FABP3, FLT3, GRM1, GRM5, IGF1R, KDR, MET, MMP12, MMP9, PPARA, PPARD, PRKCA, PTPN1, RORC, SRC, TOP2A, XDH |
3.2123 |
[BP] GO:0014075 |
None
|
DRD1, DRD2, DRD3, DRD4 |
3.19785 |
[BP] GO:0010604 |
positive regulation of macromolecule metabolic process
|
AURKB, CDC25B, CSNK2A1, DRD1, DRD2, DRD3, DRD4, F3, FLT3, GRM1, GRM5, IGF1R, KDR, MET, MMP12, MMP9, PPARA, PPARD, PRKCA, PTPN1, RORC, SRC, TOP2A, XDH |
3.17652 |
[BP] GO:0015872 |
None
|
DRD1, SLC6A2, SLC6A3 |
3.17652 |
[BP] GO:0009893 |
positive regulation of metabolic process
|
AURKB, CDC25B, CSNK2A1, DRD1, DRD2, DRD3, DRD4, F3, FABP3, FLT3, GRM1, GRM5, IGF1R, KDR, MET, MMP12, MMP9, PPARA, PPARD, PRKCA, PTPN1, RORC, SRC, TOP2A, XDH |
3.17652 |
[BP] GO:0010038 |
response to metal ion
|
CA2, CYP1A1, CYP1A2, DRD2, FABP4, GLRA1, MMP9, SLC6A3 |
3.17652 |
[BP] GO:1901564 |
organonitrogen compound metabolic process
|
ACHE, AKR1B1, AURKB, AXL, CDC25B, CSNK2A1, CYP1A1, CYP1A2, CYP3A4, DRD1, DRD2, DRD3, DRD4, F3, FLT3, GLO1, IGF1R, KDR, MET, MMP1, MMP12, MMP2, MMP9, PIM1, PPARA, PPARD, PRKCA, PTPN1, SLC6A3, SRC, TOP2A, TYR, XDH |
3.16324 |
[BP] GO:0044237 |
cellular metabolic process
|
ACHE, AKR1B1, AKR1B10, ALOX5, APEX1, AURKB, AXL, CA1, CA12, CA2, CA4, CA7, CDC25B, CSNK2A1, CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP3A4, DRD1, DRD2, DRD3, DRD4, FABP3, FABP4, FLT3, GLO1, HSD17B1, HSD17B2, IGF1R, KDR, MET, MMP1, MMP2, PIM1, PPARA, PPARD, PRKCA, PTPN1, RORC, SLC6A3, SRC, TOP2A, TYR, XDH |
3.15284 |
[BP] GO:0009987 |
cellular process
|
ACHE, ADORA3, AKR1B1, AKR1B10, ALOX5, APEX1, AURKB, AXL, CA1, CA12, CA2, CA4, CA7, CDC25B, CSNK2A1, CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP3A4, DRD1, DRD2, DRD3, DRD4, F3, FABP3, FABP4, FLT3, GLO1, GLRA1, GRIA2, GRIA4, GRIK5, GRM1, GRM3, GRM5, GRM8, HSD17B1, HSD17B2, IGF1R, KDR, MET, MMP1, MMP12, MMP2, MMP9, PIM1, PPARA, PPARD, PRKCA, PTPN1, RORC, SLC1A1, SLC6A2, SLC6A3, SRC, TOP2A, TYR, XDH |
3.13268 |
[BP] GO:0032502 |
developmental process
|
ACHE, AKR1B1, APEX1, AURKB, AXL, CA2, CDC25B, CSNK2A1, CYP19A1, CYP1A1, CYP1A2, CYP1B1, DRD1, DRD2, FABP4, FLT3, GLO1, HSD17B2, KDR, MET, MMP2, MMP9, PIM1, PPARA, PPARD, PRKCA, RORC, SLC6A3, SRC, TOP2A, TYR |
3.09066 |
[BP] GO:0060359 |
None
|
DRD1, DRD2, DRD3, DRD4, SLC6A3 |
3.08133 |
[BP] GO:0006703 |
estrogen biosynthetic process
|
CYP19A1, HSD17B1, HSD17B2 |
3.07652 |
[BP] GO:2001023 |
None
|
DRD1, DRD2, DRD3, DRD4, MET |
3.06144 |
[BP] GO:0051049 |
regulation of transport
|
ACHE, AXL, CA2, CA7, CYP19A1, DRD1, DRD2, DRD3, DRD4, GRIK5, GRM5, MMP12, MMP9, PPARA, PPARD, PRKCA, PTPN1, SRC |
3.05941 |
[BP] GO:0051588 |
None
|
DRD1, DRD2, DRD3, DRD4, GRIK5 |
3.0477 |
[BP] GO:0023052 |
None
|
DRD1, DRD2, DRD3, GLRA1, GRIA2, GRIK5, GRM1, GRM3, GRM5, SLC1A1, SLC6A2 |
3.0477 |
[BP] GO:0042325 |
regulation of phosphorylation
|
CDC25B, DRD1, DRD2, DRD4, FABP4, FLT3, GRM1, GRM5, IGF1R, KDR, MMP9, PPARA, PRKCA, PTPN1, SRC, XDH |
3.00494 |
[BP] GO:0009628 |
response to abiotic stimulus
|
AKR1B1, AURKB, CA2, CYP1A1, DRD1, DRD2, DRD3, GRM1, MMP2, PPARA, PPARD, SRC, TYR |
2.99004 |
[BP] GO:0050790 |
regulation of catalytic activity
|
ADORA3, AURKB, CDC25B, CSNK2A1, DRD1, DRD2, DRD3, DRD4, F3, FABP4, FLT3, GRM1, GRM3, GRM5, IGF1R, MMP9, PRKCA, PTPN1, SRC, XDH |
2.94562 |
[BP] GO:0097366 |
None
|
DRD1, DRD2, DRD3, DRD4 |
2.94187 |
[BP] GO:0007154 |
None
|
AXL, DRD1, DRD2, DRD3, GLRA1, GRIA2, GRIK5, GRM1, GRM3, GRM5, SLC1A1, SLC6A2 |
2.90645 |
[BP] GO:0048513 |
animal organ development
|
ACHE, AXL, CA2, CSNK2A1, CYP19A1, CYP1A1, CYP1A2, FLT3, HSD17B2, KDR, PPARA, PPARD, SRC, TYR |
2.90522 |
[BP] GO:0001963 |
None
|
DRD1, DRD2, DRD3 |
2.90522 |
[BP] GO:0051937 |
None
|
DRD1, SLC6A2, SLC6A3 |
2.90522 |
[BP] GO:0001932 |
regulation of protein phosphorylation
|
CDC25B, DRD1, DRD2, DRD4, FABP4, FLT3, GRM1, GRM5, IGF1R, KDR, MMP9, PRKCA, PTPN1, SRC, XDH |
2.8273 |
[BP] GO:0000302 |
response to reactive oxygen species
|
AKR1B1, APEX1, AXL, CYP1B1, MMP9, SRC |
2.79941 |
[BP] GO:0006796 |
phosphate-containing compound metabolic process
|
ACHE, APEX1, AURKB, AXL, CDC25B, CSNK2A1, DRD1, DRD2, FLT3, IGF1R, KDR, MET, PIM1, PPARD, PRKCA, PTPN1, SRC, XDH |
2.7744 |
[BP] GO:0045787 |
positive regulation of cell cycle
|
APEX1, AURKB, CDC25B, CYP1A1, DRD2, DRD3, PRKCA, SRC |
2.75745 |
[BP] GO:0001504 |
None
|
SLC1A1, SLC6A2, SLC6A3 |
2.74998 |
[BP] GO:0009611 |
response to wounding
|
ACHE, ADORA3, CYP1A1, DRD2, PPARA, PPARD |
2.74139 |
[BP] GO:0046942 |
None
|
DRD2, DRD3, DRD4, FABP3, PPARA, PPARD, SLC1A1 |
2.74139 |
[BP] GO:0042542 |
response to hydrogen peroxide
|
AKR1B1, APEX1, AXL, CYP1B1, SRC |
2.70313 |
[BP] GO:0015909 |
None
|
DRD2, DRD3, DRD4, FABP3 |
2.69109 |
[BP] GO:0015849 |
None
|
DRD2, DRD3, DRD4, FABP3, PPARA, PPARD, SLC1A1 |
2.66709 |
[BP] GO:0018108 |
peptidyl-tyrosine phosphorylation
|
AXL, FLT3, IGF1R, KDR, MET, SRC |
2.65822 |
[BP] GO:0032102 |
negative regulation of response to external stimulus
|
CYP19A1, DRD1, DRD2, DRD3, PPARA, PPARD, SLC6A3 |
2.65074 |
[BP] GO:0032922 |
None
|
DRD2, DRD3, PPARA, RORC |
2.63421 |
[BP] GO:0018212 |
peptidyl-tyrosine modification
|
AXL, FLT3, IGF1R, KDR, MET, SRC |
2.62729 |
[BP] GO:0006468 |
protein phosphorylation
|
AURKB, AXL, CDC25B, CSNK2A1, DRD1, FLT3, IGF1R, KDR, MET, PIM1, PRKCA, SRC |
2.62729 |
[BP] GO:0043410 |
positive regulation of MAPK cascade
|
DRD2, DRD4, FLT3, GRM1, KDR, PRKCA, PTPN1, SRC, XDH |
2.62729 |
[BP] GO:0042069 |
None
|
DRD1, DRD4, SLC6A3 |
2.62729 |
[BP] GO:0042053 |
None
|
DRD1, DRD4, SLC6A3 |
2.62729 |
[BP] GO:0006805 |
xenobiotic metabolic process
|
CYP1A1, CYP1A2, CYP1B1, CYP3A4, RORC |
2.61514 |
[BP] GO:0099566 |
None
|
GRM1, GRM5 |
2.61514 |
[BP] GO:0051944 |
None
|
DRD2, DRD4 |
2.61514 |
[BP] GO:0060160 |
None
|
DRD2, DRD3 |
2.61514 |
[BP] GO:0032849 |
positive regulation of cellular pH reduction
|
CA2, CA7 |
2.61514 |
[BP] GO:0051586 |
None
|
DRD2, DRD4 |
2.61514 |
[BP] GO:0071417 |
cellular response to organonitrogen compound
|
AKR1B1, APEX1, DRD1, GLRA1, GRM5, IGF1R, MMP2, SRC |
2.61116 |
[BP] GO:0001934 |
positive regulation of protein phosphorylation
|
CDC25B, DRD2, DRD4, FLT3, GRM1, GRM5, KDR, MMP9, PRKCA, PTPN1, SRC, XDH |
2.61002 |
[BP] GO:0034599 |
cellular response to oxidative stress
|
AKR1B1, APEX1, AXL, CYP1B1, MMP9, SRC |
2.59557 |
[BP] GO:0019222 |
regulation of metabolic process
|
ACHE, ADORA3, APEX1, AURKB, CDC25B, CSNK2A1, CYP1A1, CYP1A2, CYP1B1, DRD1, DRD2, DRD3, DRD4, F3, FABP3, FABP4, FLT3, GLO1, GRM1, GRM3, GRM5, GRM8, IGF1R, KDR, MET, MMP12, MMP9, PIM1, PPARA, PPARD, PRKCA, PTPN1, RORC, SLC6A3, SRC, TOP2A, XDH |
2.58962 |
[BP] GO:0006793 |
phosphorus metabolic process
|
ACHE, APEX1, AURKB, AXL, CDC25B, CSNK2A1, DRD1, DRD2, FLT3, IGF1R, KDR, MET, PIM1, PPARD, PRKCA, PTPN1, SRC, XDH |
2.56525 |
[BP] GO:0070988 |
demethylation
|
APEX1, CYP1A1, CYP1A2, CYP3A4 |
2.55449 |
[BP] GO:0006631 |
fatty acid metabolic process
|
ALOX5, CYP1A1, CYP1A2, CYP1B1, FABP3, PPARA, PPARD |
2.5351 |
[BP] GO:0015844 |
None
|
DRD1, SLC6A2, SLC6A3 |
2.52889 |
[BP] GO:0019373 |
epoxygenase P450 pathway
|
CYP1A1, CYP1A2, CYP1B1 |
2.52889 |
[BP] GO:0050806 |
positive regulation of synaptic transmission
|
CA2, CA7, DRD1, DRD2, DRD4 |
2.5258 |
[BP] GO:0050801 |
ion homeostasis
|
CA12, CA2, CA7, DRD1, DRD2, DRD3, DRD4, FABP3, GRM1, GRM5 |
2.52424 |
[BP] GO:0080090 |
regulation of primary metabolic process
|
ADORA3, APEX1, AURKB, CDC25B, CSNK2A1, CYP1A1, CYP1B1, DRD1, DRD2, DRD3, DRD4, F3, FABP3, FABP4, FLT3, GLO1, GRM1, GRM3, GRM5, GRM8, IGF1R, KDR, MET, MMP12, MMP9, PIM1, PPARA, PPARD, PRKCA, PTPN1, RORC, SLC6A3, SRC, TOP2A, XDH |
2.5187 |
[BP] GO:0070301 |
cellular response to hydrogen peroxide
|
AKR1B1, APEX1, AXL, CYP1B1 |
2.51329 |
[BP] GO:0048583 |
regulation of response to stimulus
|
AKR1B1, AURKB, AXL, CSNK2A1, CYP19A1, CYP1B1, DRD1, DRD2, DRD3, DRD4, F3, FABP4, FLT3, GRM1, IGF1R, KDR, MET, MMP12, MMP2, MMP9, PPARA, PPARD, PRKCA, PTPN1, SLC6A3, SRC, XDH |
2.51204 |
[BP] GO:0007167 |
enzyme linked receptor protein signaling pathway
|
AXL, FLT3, IGF1R, KDR, MET, MMP2, MMP9, PRKCA, PTPN1, SRC |
2.5049 |
[BP] GO:0006810 |
None
|
ACHE, ALOX5, AXL, CA1, CA12, CA14, CA2, CA4, CA7, DRD1, DRD2, DRD3, DRD4, FABP3, GLRA1, GRIA2, GRIA4, GRIK5, MMP12, MMP9, PPARA, PPARD, SLC1A1, SLC6A2, SLC6A3, SRC, XDH |
2.50444 |
[BP] GO:0065009 |
regulation of molecular function
|
ADORA3, AURKB, CDC25B, CSNK2A1, CYP1B1, DRD1, DRD2, DRD3, DRD4, F3, FABP4, FLT3, GRM1, GRM3, GRM5, IGF1R, MET, MMP9, PIM1, PPARA, PRKCA, PTPN1, SRC, XDH |
2.49828 |
[BP] GO:0007610 |
None
|
DRD1, DRD2, DRD3, DRD4, GLRA1, GRM1, GRM5, PPARA, SLC6A3 |
2.49828 |
[BP] GO:0010634 |
positive regulation of epithelial cell migration
|
KDR, MET, MMP9, PRKCA, SRC |
2.47396 |
[BP] GO:1903530 |
regulation of secretion by cell
|
ACHE, CYP19A1, DRD2, DRD3, DRD4, GRIK5, MMP12, PPARD, PRKCA, SRC |
2.47073 |
[BP] GO:0031323 |
regulation of cellular metabolic process
|
ACHE, ADORA3, APEX1, AURKB, CDC25B, CSNK2A1, CYP1B1, DRD1, DRD2, DRD3, DRD4, F3, FABP3, FABP4, FLT3, GLO1, GRM1, GRM3, GRM5, GRM8, IGF1R, KDR, MET, MMP12, MMP9, PIM1, PPARA, PPARD, PRKCA, PTPN1, RORC, SLC6A3, SRC, TOP2A, XDH |
2.47073 |
[BP] GO:0006694 |
steroid biosynthetic process
|
AKR1B1, CYP19A1, CYP3A4, HSD17B1, HSD17B2 |
2.46217 |
[BP] GO:0042327 |
positive regulation of phosphorylation
|
CDC25B, DRD2, DRD4, FLT3, GRM1, GRM5, KDR, MMP9, PRKCA, PTPN1, SRC, XDH |
2.46217 |
[BP] GO:0050708 |
None
|
ACHE, DRD2, DRD3, DRD4, MMP12, PPARD, PRKCA, SRC |
2.43831 |
[BP] GO:1903963 |
None
|
DRD2, DRD3, DRD4 |
2.43619 |
[BP] GO:0050482 |
None
|
DRD2, DRD3, DRD4 |
2.43619 |
[BP] GO:0009404 |
toxin metabolic process
|
CYP1A1, CYP1A2, CYP1B1 |
2.43619 |
[BP] GO:0008610 |
lipid biosynthetic process
|
ACHE, AKR1B1, CSNK2A1, CYP19A1, CYP1A1, CYP3A4, HSD17B1, HSD17B2, PPARD |
2.43354 |
[BP] GO:0030574 |
collagen catabolic process
|
MMP1, MMP12, MMP2, MMP9 |
2.42898 |
[BP] GO:1901699 |
cellular response to nitrogen compound
|
AKR1B1, APEX1, DRD1, GLRA1, GRM5, IGF1R, MMP2, SRC |
2.41868 |
[BP] GO:0051240 |
positive regulation of multicellular organismal process
|
AXL, CA2, CYP1B1, DRD2, DRD3, F3, KDR, MET, MMP12, MMP9, PIM1, PRKCA, SLC1A1, SLC6A3, SRC |
2.4033 |
[BP] GO:0051234 |
None
|
ACHE, ALOX5, AXL, CA1, CA12, CA14, CA2, CA4, CA7, DRD1, DRD2, DRD3, DRD4, FABP3, GLRA1, GRIA2, GRIA4, GRIK5, MMP12, MMP9, PPARA, PPARD, SLC1A1, SLC6A2, SLC6A3, SRC, XDH |
2.38845 |
[BP] GO:1903409 |
reactive oxygen species biosynthetic process
|
CYP1A1, CYP1A2, CYP1B1 |
2.38814 |
[BP] GO:0032847 |
regulation of cellular pH reduction
|
CA2, CA7 |
2.38411 |
[BP] GO:0051582 |
None
|
DRD2, DRD4 |
2.38411 |
[BP] GO:0018894 |
dibenzo-p-dioxin metabolic process
|
CYP1A1, CYP1A2 |
2.38411 |
[BP] GO:0032465 |
None
|
AURKB, CDC25B, DRD2, DRD3 |
2.368 |
[BP] GO:0001101 |
response to acid chemical
|
AKR1B1, FABP3, GLRA1, HSD17B2, KDR, MMP2, SRC |
2.35894 |
[BP] GO:0042180 |
None
|
AKR1B1, AKR1B10, CYP19A1, GLO1 |
2.34882 |
[BP] GO:0060079 |
None
|
GLRA1, GRIA2, GRIA4, GRIK5 |
2.34882 |
[BP] GO:0051171 |
regulation of nitrogen compound metabolic process
|
ADORA3, APEX1, AURKB, CDC25B, CSNK2A1, CYP1B1, DRD1, DRD2, DRD3, DRD4, F3, FABP3, FABP4, FLT3, GLO1, GRM1, GRM3, GRM5, GRM8, IGF1R, KDR, MET, MMP12, MMP9, PIM1, PPARA, PPARD, PRKCA, PTPN1, RORC, SLC6A3, SRC, TOP2A, XDH |
2.34536 |
[BP] GO:0030335 |
positive regulation of cell migration
|
DRD1, F3, IGF1R, KDR, MET, MMP9, PRKCA, SRC |
2.34392 |
[BP] GO:0043408 |
regulation of MAPK cascade
|
DRD2, DRD4, FLT3, GRM1, IGF1R, KDR, PRKCA, PTPN1, SRC, XDH |
2.32389 |
[BP] GO:0006706 |
steroid catabolic process
|
CYP19A1, CYP1A2, CYP3A4 |
2.30719 |
[BP] GO:0035235 |
None
|
GRIA2, GRIA4, GRIK5 |
2.30719 |
[BP] GO:0032309 |
None
|
DRD2, DRD3, DRD4 |
2.30719 |
[BP] GO:0032846 |
positive regulation of homeostatic process
|
AURKB, CA2, CA7, DRD1, DRD2, DRD3 |
2.30537 |
[BP] GO:0018193 |
peptidyl-amino acid modification
|
AURKB, AXL, CSNK2A1, DRD1, FLT3, IGF1R, KDR, MET, PRKCA, SRC, TOP2A |
2.29497 |
[BP] GO:0002791 |
None
|
ACHE, DRD2, DRD3, DRD4, MMP12, PPARD, PRKCA, SRC |
2.28725 |
[BP] GO:0044243 |
multicellular organismal catabolic process
|
MMP1, MMP12, MMP2, MMP9 |
2.26831 |
[BP] GO:0043086 |
negative regulation of catalytic activity
|
CSNK2A1, DRD2, DRD3, DRD4, FABP4, GRM3, IGF1R, MMP9, PRKCA, PTPN1, SRC |
2.26831 |
[BP] GO:0007628 |
None
|
DRD1, DRD2, GLRA1 |
2.26666 |
[BP] GO:0051046 |
None
|
ACHE, CYP19A1, DRD2, DRD3, DRD4, GRIK5, MMP12, PPARD, PRKCA, SRC |
2.25962 |
[BP] GO:2000147 |
positive regulation of cell motility
|
DRD1, F3, IGF1R, KDR, MET, MMP9, PRKCA, SRC |
2.25558 |
[BP] GO:0045931 |
positive regulation of mitotic cell cycle
|
APEX1, CDC25B, CYP1A1, DRD3, PRKCA |
2.24245 |
[BP] GO:0032413 |
None
|
DRD2, DRD3, DRD4, MMP9 |
2.23321 |
[BP] GO:0016572 |
histone phosphorylation
|
AURKB, DRD1, PRKCA |
2.22786 |
[BP] GO:0090659 |
None
|
DRD1, DRD2, GLRA1 |
2.22786 |
[BP] GO:0071702 |
None
|
CA1, CA12, CA14, CA2, CA4, CA7, DRD1, DRD2, DRD3, DRD4, FABP3, MMP12, PPARA, PPARD, SLC1A1, SLC6A2, SLC6A3 |
2.22468 |
[BP] GO:0009410 |
None
|
DRD1, DRD2, DRD3, DRD4, SLC6A3 |
2.22218 |
[BP] GO:0051952 |
None
|
DRD1, DRD2, DRD3, DRD4 |
2.21741 |
[BP] GO:0031324 |
negative regulation of cellular metabolic process
|
APEX1, AURKB, CSNK2A1, DRD2, DRD3, DRD4, FABP4, GRM3, GRM8, IGF1R, MET, MMP12, MMP9, PPARA, PPARD, PRKCA, PTPN1, RORC, SRC, XDH |
2.21621 |
[BP] GO:0021853 |
None
|
DRD1, DRD2 |
2.21121 |
[BP] GO:0010641 |
None
|
F3, SRC |
2.21121 |
[BP] GO:1904936 |
None
|
DRD1, DRD2 |
2.21121 |
[BP] GO:0090325 |
None
|
DRD2, DRD3 |
2.21121 |
[BP] GO:0015893 |
None
|
CA2, DRD1, SLC1A1, SLC6A2, SLC6A3 |
2.207 |
[BP] GO:0071248 |
cellular response to metal ion
|
CYP1A1, CYP1A2, FABP4, GLRA1, MMP9 |
2.207 |
[BP] GO:0046717 |
None
|
DRD2, DRD3, DRD4, SLC1A1 |
2.207 |
[BP] GO:0045934 |
None
|
APEX1, AURKB, DRD2, DRD3, DRD4, FABP4, GRM3, GRM8, MMP12, PPARA, PPARD, PRKCA, RORC, SRC |
2.20099 |
[BP] GO:0071715 |
None
|
DRD2, DRD3, DRD4 |
2.20099 |
[BP] GO:1901571 |
None
|
DRD2, DRD3, DRD4 |
2.20099 |
[BP] GO:0050789 |
regulation of biological process
|
ACHE, ADORA3, AKR1B1, APEX1, AURKB, AXL, CA1, CA2, CA7, CDC25B, CSNK2A1, CYP19A1, CYP1A1, CYP1A2, CYP1B1, DRD1, DRD2, DRD3, DRD4, F3, FABP3, FABP4, FLT3, GLO1, GLRA1, GRIA2, GRIA4, GRIK5, GRM1, GRM3, GRM5, GRM8, IGF1R, KDR, MET, MMP1, MMP12, MMP2, MMP9, PIM1, PPARA, PPARD, PRKCA, PTPN1, RORC, SLC1A1, SLC6A3, SRC, TOP2A, XDH |
2.20096 |
[BP] GO:0051272 |
positive regulation of cellular component movement
|
DRD1, F3, IGF1R, KDR, MET, MMP9, PRKCA, SRC |
2.20008 |
[BP] GO:1901652 |
response to peptide
|
AKR1B1, APEX1, FABP3, GRM5, IGF1R, PPARA, SRC |
2.19546 |
[BP] GO:0008344 |
None
|
DRD1, DRD2, DRD4, GLRA1 |
2.19407 |
[BP] GO:0071407 |
cellular response to organic cyclic compound
|
APEX1, CYP1A1, CYP1B1, DRD1, FLT3, RORC, SRC |
2.18255 |
[BP] GO:0032844 |
regulation of homeostatic process
|
AURKB, CA2, CA7, DRD1, DRD2, DRD3, KDR, SRC |
2.17972 |
[BP] GO:0022617 |
extracellular matrix disassembly
|
MMP1, MMP12, MMP2, MMP9 |
2.17628 |
[BP] GO:0032787 |
None
|
ALOX5, CYP1A1, CYP1A2, CYP1B1, FABP3, GLO1, PPARA, PPARD |
2.1583 |
[BP] GO:0032963 |
collagen metabolic process
|
MMP1, MMP12, MMP2, MMP9 |
2.13775 |
[BP] GO:0051179 |
None
|
ACHE, ALOX5, AURKB, AXL, CA1, CA12, CA14, CA2, CA4, CA7, DRD1, DRD2, DRD3, DRD4, FABP3, GLRA1, GRIA2, GRIA4, GRIK5, MMP12, MMP9, PPARA, PPARD, SLC1A1, SLC6A2, SLC6A3, SRC, XDH |
2.13292 |
[BP] GO:0042220 |
None
|
DRD2, DRD3, SLC6A3 |
2.13292 |
[BP] GO:0045744 |
None
|
DRD2, DRD3, MET |
2.13292 |
[BP] GO:0010039 |
response to iron ion
|
CYP1A1, DRD2, SLC6A3 |
2.13292 |
[BP] GO:0050794 |
regulation of cellular process
|
ACHE, ADORA3, AKR1B1, APEX1, AURKB, AXL, CA1, CA2, CA7, CDC25B, CSNK2A1, CYP19A1, CYP1A1, CYP1B1, DRD1, DRD2, DRD3, DRD4, F3, FABP3, FABP4, FLT3, GLO1, GLRA1, GRIA2, GRIA4, GRIK5, GRM1, GRM3, GRM5, GRM8, IGF1R, KDR, MET, MMP1, MMP12, MMP2, MMP9, PIM1, PPARA, PPARD, PRKCA, PTPN1, RORC, SLC6A3, SRC, TOP2A, XDH |
2.12537 |
[BP] GO:0080134 |
regulation of response to stress
|
CYP19A1, DRD2, F3, FABP4, IGF1R, MET, MMP12, MMP2, PPARA, PPARD, PRKCA, PTPN1, SRC, XDH |
2.12159 |
[BP] GO:0040017 |
positive regulation of locomotion
|
DRD1, F3, IGF1R, KDR, MET, MMP9, PRKCA, SRC |
2.11485 |
[BP] GO:0051172 |
None
|
APEX1, AURKB, CSNK2A1, DRD2, DRD3, DRD4, FABP4, GRM3, GRM8, IGF1R, MMP12, MMP9, PPARA, PPARD, PRKCA, PTPN1, RORC, SRC, XDH |
2.11243 |
[BP] GO:0019216 |
regulation of lipid metabolic process
|
CYP1A1, DRD3, FABP3, FLT3, PPARA, RORC, SRC |
2.11243 |
[BP] GO:0032410 |
None
|
DRD2, DRD3, DRD4, MMP9 |
2.11243 |
[BP] GO:1904063 |
None
|
DRD2, DRD3, DRD4, MMP9 |
2.11243 |
[BP] GO:0032228 |
regulation of synaptic transmission, GABAergic
|
CA2, CA7, DRD2 |
2.10078 |
[BP] GO:0051781 |
None
|
AURKB, CDC25B, DRD2, DRD3 |
2.09463 |
[BP] GO:0021843 |
None
|
DRD1, DRD2 |
2.09202 |
[BP] GO:0021830 |
None
|
DRD1, DRD2 |
2.09202 |
[BP] GO:0032415 |
None
|
DRD3, DRD4 |
2.09202 |
[BP] GO:0051934 |
None
|
SLC6A2, SLC6A3 |
2.09202 |
[BP] GO:0021984 |
None
|
DRD2, SLC6A3 |
2.09202 |
[BP] GO:0090494 |
None
|
SLC6A2, SLC6A3 |
2.09202 |
[BP] GO:0090493 |
None
|
SLC6A2, SLC6A3 |
2.09202 |
[BP] GO:0051583 |
None
|
SLC6A2, SLC6A3 |
2.09202 |
[BP] GO:0002933 |
lipid hydroxylation
|
CYP1A1, CYP3A4 |
2.09202 |
[BP] GO:0021826 |
None
|
DRD1, DRD2 |
2.09202 |
[BP] GO:0016098 |
monoterpenoid metabolic process
|
CYP1A2, CYP3A4 |
2.09202 |
[BP] GO:0019725 |
cellular homeostasis
|
APEX1, CA2, CA7, DRD1, DRD2, DRD3, DRD4, GRIK5, GRM1, GRM5 |
2.08782 |
[BP] GO:0006775 |
fat-soluble vitamin metabolic process
|
CYP1A1, CYP3A4, PPARD |
2.08131 |
[BP] GO:1901617 |
organic hydroxy compound biosynthetic process
|
AKR1B1, CYP19A1, CYP3A4, SLC6A3, TYR |
2.07932 |
[BP] GO:0045859 |
regulation of protein kinase activity
|
CDC25B, DRD2, DRD4, FABP4, FLT3, GRM1, GRM5, IGF1R, PTPN1, SRC |
2.07932 |
[BP] GO:0048585 |
negative regulation of response to stimulus
|
CYP19A1, DRD1, DRD2, DRD3, IGF1R, MET, MMP12, MMP9, PPARA, PPARD, PTPN1, SLC6A3, SRC, XDH |
2.07932 |
[BP] GO:0044259 |
multicellular organismal macromolecule metabolic process
|
MMP1, MMP12, MMP2, MMP9 |
2.07932 |
[BP] GO:0001666 |
response to hypoxia
|
CYP1A1, DRD2, MMP2, PPARA, PPARD, SRC |
2.07437 |
[BP] GO:0098771 |
inorganic ion homeostasis
|
CA12, CA2, CA7, DRD1, DRD2, DRD3, DRD4, GRM1, GRM5 |
2.06371 |
[BP] GO:0051050 |
positive regulation of transport
|
ACHE, AXL, CA2, CYP19A1, DRD1, DRD2, DRD3, DRD4, MMP12, PPARD, SRC |
2.03234 |
[BP] GO:0009892 |
negative regulation of metabolic process
|
APEX1, AURKB, CSNK2A1, DRD2, DRD3, DRD4, FABP4, GRM3, GRM8, IGF1R, KDR, MET, MMP12, MMP9, PPARA, PPARD, PRKCA, PTPN1, RORC, SRC, XDH |
2.03234 |
[BP] GO:0048856 |
anatomical structure development
|
ACHE, AKR1B1, AXL, CA2, CSNK2A1, CYP19A1, CYP1A1, CYP1A2, CYP1B1, DRD1, DRD2, FLT3, HSD17B2, KDR, MMP9, PIM1, PPARA, PPARD, RORC, SLC6A3, SRC, TYR |
2.02751 |
[BP] GO:0030336 |
None
|
ADORA3, APEX1, CYP19A1, CYP1B1, DRD2, PPARD |
2.02704 |
[BP] GO:0021885 |
forebrain cell migration
|
AXL, DRD1, DRD2 |
2.01763 |
[BP] GO:0055082 |
cellular chemical homeostasis
|
CA2, CA7, DRD1, DRD2, DRD3, DRD4, GRIK5, GRM1, GRM5 |
2.01677 |
[BP] GO:0051047 |
None
|
ACHE, CYP19A1, DRD2, DRD3, MMP12, PPARD, SRC |
2.01677 |
[BP] GO:0001523 |
None
|
AKR1B10, CYP1A1, CYP1B1, PPARD |
2.01677 |
[BP] GO:0006869 |
None
|
DRD2, DRD3, DRD4, FABP3, PPARA, PPARD |
2.01677 |
[BP] GO:0036293 |
response to decreased oxygen levels
|
CYP1A1, DRD2, MMP2, PPARA, PPARD, SRC |
2.01677 |
[BP] GO:0008283 |
cell proliferation
|
ACHE, AURKB, CYP1A1, FLT3, MET, PIM1, PPARD, SRC, TYR |
2.01677 |
[BP] GO:0045860 |
positive regulation of protein kinase activity
|
CDC25B, DRD2, DRD4, FLT3, GRM1, GRM5, PTPN1, SRC |
2.00851 |
[CC] GO:0031226 |
intrinsic component of plasma membrane
|
ADORA3, AXL, CA4, DRD1, DRD2, DRD3, DRD4, F3, FLT3, GLRA1, GRIA2, GRM1, GRM3, GRM5, GRM8, IGF1R, KDR, MET, SLC1A1, SLC6A2, SLC6A3 |
6.05079 |
[CC] GO:0005886 |
plasma membrane
|
ACHE, ADORA3, AXL, CA12, CA14, CA2, CA4, CSNK2A1, DRD1, DRD2, DRD3, DRD4, F3, FLT3, GLO1, GLRA1, GRIA2, GRIA4, GRIK5, GRM1, GRM3, GRM5, GRM8, IGF1R, KDR, MET, MMP2, PIM1, PRKCA, PTPN1, SLC1A1, SLC6A2, SLC6A3, SRC |
5.34684 |
[CC] GO:0005887 |
integral component of plasma membrane
|
ADORA3, AXL, DRD1, DRD2, DRD3, DRD4, FLT3, GLRA1, GRIA2, GRM1, GRM3, GRM5, GRM8, IGF1R, KDR, MET, SLC1A1, SLC6A2, SLC6A3 |
5.15338 |
[CC] GO:0044459 |
plasma membrane part
|
ADORA3, AXL, CA2, CA4, DRD1, DRD2, DRD3, DRD4, F3, FLT3, GLRA1, GRIA2, GRIA4, GRIK5, GRM1, GRM3, GRM5, GRM8, IGF1R, KDR, MET, SLC1A1, SLC6A2, SLC6A3, SRC |
4.65521 |
[CC] GO:0044456 |
None
|
ACHE, DRD2, DRD4, GLRA1, GRIA2, GRIA4, GRIK5, GRM1, GRM3, GRM5, GRM8, SLC6A3, SRC |
4.52431 |
[CC] GO:0098590 |
plasma membrane region
|
CA2, CA4, DRD1, DRD2, GLRA1, GRIA2, GRIA4, GRIK5, GRM1, GRM3, GRM5, GRM8, MET, SLC1A1, SRC |
4.42348 |
[CC] GO:0042734 |
None
|
GRIK5, GRM1, GRM3, GRM5, GRM8 |
3.72412 |
[CC] GO:0097060 |
None
|
GLRA1, GRIA2, GRIA4, GRIK5, GRM1, GRM3, GRM5, GRM8 |
3.45393 |
[CC] GO:0016020 |
membrane
|
ACHE, ADORA3, ALOX5, AXL, CA12, CA14, CA2, CA4, CSNK2A1, CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP3A4, DRD1, DRD2, DRD3, DRD4, F3, FLT3, GLO1, GLRA1, GRIA2, GRIA4, GRIK5, GRM1, GRM3, GRM5, GRM8, HSD17B2, IGF1R, KDR, MET, MMP2, PIM1, PRKCA, PTPN1, SLC1A1, SLC6A2, SLC6A3, SRC, TYR |
3.32659 |
[CC] GO:0043005 |
None
|
CA2, DRD2, GLRA1, GRIA2, GRIA4, GRIK5, GRM1, GRM3, GRM5, SLC6A2, SLC6A3, SRC |
3.25013 |
[CC] GO:0042995 |
cell projection
|
AKR1B1, CA2, DRD1, DRD2, DRD3, GLRA1, GRIA2, GRIA4, GRIK5, GRM1, GRM3, GRM5, SLC6A2, SLC6A3, SRC |
2.81062 |
[CC] GO:0014069 |
None
|
DRD2, GRIK5, GRM1, GRM3, GRM5, SRC |
2.55413 |
[CC] GO:0099572 |
None
|
DRD2, GRIK5, GRM1, GRM3, GRM5, SRC |
2.55413 |
[CC] GO:0120025 |
None
|
AKR1B1, CA2, DRD1, DRD2, GLRA1, GRIA2, GRIA4, GRIK5, GRM1, GRM3, GRM5, SLC6A2, SLC6A3, SRC |
2.52206 |
[CC] GO:0044425 |
membrane part
|
ACHE, ADORA3, AXL, CA12, CA14, CA2, CA4, CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP3A4, DRD1, DRD2, DRD3, DRD4, F3, FLT3, GLRA1, GRIA2, GRIA4, GRIK5, GRM1, GRM3, GRM5, GRM8, HSD17B2, IGF1R, KDR, MET, PTPN1, SLC1A1, SLC6A2, SLC6A3, SRC, TYR |
2.36371 |
[CC] GO:0098794 |
None
|
DRD2, DRD4, GRIA2, GRIA4, GRM3 |
2.16673 |
[CC] GO:0097443 |
sorting endosome
|
KDR, PTPN1 |
2.09202 |
[MF] GO:0046914 |
transition metal ion binding
|
ALOX5, CA1, CA12, CA2, CA4, CA7, CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP3A4, GLO1, GLRA1, MMP1, MMP12, MMP2, MMP9, PIM1, PPARA, PPARD, PRKCA, PTPN1, RORC, TYR, XDH |
11.2792 |
[MF] GO:0043167 |
ion binding
|
ACHE, ALOX5, APEX1, AURKB, AXL, CA1, CA12, CA14, CA2, CA4, CA7, CSNK2A1, CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP3A4, DRD1, DRD2, DRD3, DRD4, F3, FABP3, FABP4, FLT3, GLO1, GLRA1, HSD17B1, IGF1R, KDR, MET, MMP1, MMP12, MMP2, MMP9, PIM1, PPARA, PPARD, PRKCA, PTPN1, RORC, SLC1A1, SLC6A2, SLC6A3, SRC, TOP2A, TYR, XDH |
9.86958 |
[MF] GO:0030594 |
None
|
DRD1, DRD2, DRD3, DRD4, GLRA1, GRIA2, GRIA4, GRIK5, GRM1, GRM5 |
8.39993 |
[MF] GO:0008066 |
None
|
GRIA2, GRIA4, GRIK5, GRM1, GRM3, GRM5, GRM8 |
8.34929 |
[MF] GO:0004089 |
carbonate dehydratase activity
|
CA1, CA12, CA14, CA2, CA4, CA7 |
8.08457 |
[MF] GO:0008144 |
drug binding
|
ACHE, AURKB, AXL, CSNK2A1, CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP3A4, DRD1, DRD2, DRD3, DRD4, FLT3, GLRA1, IGF1R, KDR, MET, PIM1, PPARA, PPARD, PRKCA, SLC6A3, SRC, TOP2A |
7.56557 |
[MF] GO:0043169 |
cation binding
|
ACHE, ALOX5, APEX1, AURKB, CA1, CA12, CA14, CA2, CA4, CA7, CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP3A4, DRD1, DRD2, DRD3, DRD4, GLO1, GLRA1, MMP1, MMP12, MMP2, MMP9, PIM1, PPARA, PPARD, PRKCA, PTPN1, RORC, SLC1A1, SLC6A2, SLC6A3, TOP2A, TYR, XDH |
7.21577 |
[MF] GO:0038023 |
signaling receptor activity
|
ADORA3, AXL, DRD1, DRD2, DRD3, DRD4, F3, FLT3, GLRA1, GRIA2, GRIA4, GRIK5, GRM1, GRM3, GRM5, GRM8, IGF1R, KDR, MET, PPARA, PPARD, RORC |
7.03748 |
[MF] GO:0035240 |
None
|
DRD1, DRD2, DRD3, DRD4, SLC6A3 |
6.4958 |
[MF] GO:0004872 |
receptor activity
|
ADORA3, AXL, DRD1, DRD2, DRD3, DRD4, F3, FLT3, GLRA1, GRIA2, GRIA4, GRIK5, GRM1, GRM3, GRM5, GRM8, IGF1R, KDR, MET, PPARA, PPARD, RORC |
6.32456 |
[MF] GO:0060089 |
molecular transducer activity
|
ADORA3, AXL, DRD1, DRD2, DRD3, DRD4, F3, FLT3, GLRA1, GRIA2, GRIA4, GRIK5, GRM1, GRM3, GRM5, GRM8, IGF1R, KDR, MET, PPARA, PPARD, RORC |
6.13116 |
[MF] GO:0008270 |
zinc ion binding
|
CA1, CA12, CA2, CA4, CA7, GLO1, GLRA1, MMP1, MMP12, MMP2, MMP9, PPARA, PPARD, PRKCA, PTPN1, RORC |
5.91884 |
[MF] GO:0016835 |
carbon-oxygen lyase activity
|
APEX1, CA1, CA12, CA14, CA2, CA4, CA7 |
5.80665 |
[MF] GO:0004871 |
signal transducer activity
|
ADORA3, AXL, DRD1, DRD2, DRD3, DRD4, F3, FLT3, GLRA1, GRIA2, GRIA4, GRIK5, GRM1, GRM3, GRM5, GRM8, IGF1R, KDR, MET, PPARA, PPARD, RORC |
5.80665 |
[MF] GO:1901338 |
None
|
DRD1, DRD2, DRD3, DRD4, SLC6A3 |
5.78118 |
[MF] GO:0070330 |
aromatase activity
|
CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP3A4 |
5.56585 |
[MF] GO:0016712 |
oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen, reduced flavin or flavoprotein as one donor, and incorporation of one atom of oxygen
|
CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP3A4 |
5.33581 |
[MF] GO:0016836 |
hydro-lyase activity
|
CA1, CA12, CA14, CA2, CA4, CA7 |
5.27249 |
[MF] GO:0099600 |
transmembrane receptor activity
|
ADORA3, AXL, DRD1, DRD2, DRD3, DRD4, F3, FLT3, GRIA2, GRIA4, GRIK5, GRM1, GRM3, GRM5, GRM8, IGF1R, KDR, MET |
5.15338 |
[MF] GO:0004888 |
transmembrane signaling receptor activity
|
ADORA3, AXL, DRD1, DRD2, DRD3, DRD4, F3, FLT3, GRIA2, GRIA4, GRIK5, GRM1, GRM3, GRM5, GRM8, IGF1R, KDR, MET |
5.15338 |
[MF] GO:0004952 |
None
|
DRD1, DRD2, DRD3, DRD4 |
4.96455 |
[MF] GO:0003824 |
catalytic activity
|
ACHE, AKR1B1, AKR1B10, ALOX5, APEX1, AURKB, AXL, CA1, CA12, CA14, CA2, CA4, CA7, CDC25B, CSNK2A1, CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP3A4, F3, FLT3, GLO1, HSD17B1, HSD17B2, IGF1R, KDR, MET, MMP1, MMP12, MMP2, MMP9, PIM1, PRKCA, PTPN1, SRC, TOP2A, TYR, XDH |
4.88592 |
[MF] GO:0046872 |
metal ion binding
|
ALOX5, APEX1, AURKB, CA1, CA12, CA14, CA2, CA4, CA7, CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP3A4, GLO1, GLRA1, MMP1, MMP12, MMP2, MMP9, PIM1, PPARA, PPARD, PRKCA, PTPN1, RORC, SLC1A1, SLC6A2, SLC6A3, TOP2A, TYR, XDH |
4.88592 |
[MF] GO:0016829 |
lyase activity
|
APEX1, CA1, CA12, CA14, CA2, CA4, CA7, GLO1 |
4.70608 |
[MF] GO:0070405 |
ammonium ion binding
|
ACHE, DRD1, DRD2, DRD3, DRD4, SLC6A3 |
4.69656 |
[MF] GO:0019825 |
oxygen binding
|
CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP3A4 |
4.33977 |
[MF] GO:0016491 |
oxidoreductase activity
|
AKR1B1, AKR1B10, ALOX5, APEX1, CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP3A4, HSD17B1, HSD17B2, TYR, XDH |
4.32032 |
[MF] GO:0004497 |
monooxygenase activity
|
CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP3A4, TYR |
4.12014 |
[MF] GO:0005506 |
iron ion binding
|
ALOX5, CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP3A4, XDH |
4.02032 |
[MF] GO:0004714 |
transmembrane receptor protein tyrosine kinase activity
|
AXL, FLT3, IGF1R, KDR, MET |
3.72412 |
[MF] GO:0001591 |
None
|
DRD2, DRD3, DRD4 |
3.67343 |
[MF] GO:0016725 |
oxidoreductase activity, acting on CH or CH2 groups
|
CYP1A2, CYP3A4, XDH |
3.51667 |
[MF] GO:0020037 |
heme binding
|
CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP3A4, SRC |
3.45393 |
[MF] GO:0046906 |
tetrapyrrole binding
|
CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP3A4, SRC |
3.29562 |
[MF] GO:0019199 |
transmembrane receptor protein kinase activity
|
AXL, FLT3, IGF1R, KDR, MET |
3.27397 |
[MF] GO:0016705 |
oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen
|
CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP3A4, TYR |
3.05667 |
[MF] GO:0044877 |
macromolecular complex binding
|
ACHE, APEX1, CSNK2A1, FLT3, IGF1R, KDR, MMP12, MMP9, PIM1, PPARA, PTPN1, SLC6A3, SRC |
3.05667 |
[MF] GO:0005231 |
None
|
GLRA1, GRIA2, GRIA4, GRIK5 |
2.83885 |
[MF] GO:0022824 |
None
|
GLRA1, GRIA2, GRIA4, GRIK5 |
2.77734 |
[MF] GO:0022835 |
None
|
GLRA1, GRIA2, GRIA4, GRIK5 |
2.77734 |
[MF] GO:0004713 |
protein tyrosine kinase activity
|
AXL, FLT3, IGF1R, KDR, MET, SRC |
2.71762 |
[MF] GO:0004970 |
None
|
GRIA2, GRIA4, GRIK5 |
2.62729 |
[MF] GO:0005234 |
None
|
GRIA2, GRIA4, GRIK5 |
2.62729 |
[MF] GO:0070576 |
vitamin D 24-hydroxylase activity
|
CYP1A1, CYP3A4 |
2.61514 |
[MF] GO:0005330 |
None
|
SLC6A2, SLC6A3 |
2.61514 |
[MF] GO:0099583 |
None
|
GRM1, GRM5 |
2.61514 |
[MF] GO:0032403 |
protein complex binding
|
ACHE, APEX1, FLT3, IGF1R, KDR, MMP12, MMP9, PPARA, PTPN1, SLC6A3, SRC |
2.61002 |
[MF] GO:0004672 |
protein kinase activity
|
AURKB, AXL, CSNK2A1, FLT3, IGF1R, KDR, MET, PIM1, PRKCA, SRC |
2.59557 |
[MF] GO:0034875 |
caffeine oxidase activity
|
CYP1A2, CYP3A4 |
2.38411 |
[MF] GO:0004971 |
None
|
GRIA2, GRIA4 |
2.38411 |
[MF] GO:0033695 |
oxidoreductase activity, acting on CH or CH2 groups, quinone or similar compound as acceptor
|
CYP1A2, CYP3A4 |
2.38411 |
[MF] GO:0016614 |
oxidoreductase activity, acting on CH-OH group of donors
|
AKR1B1, AKR1B10, HSD17B1, HSD17B2, XDH |
2.34079 |
[MF] GO:0005504 |
None
|
FABP3, FABP4, PPARD |
2.26666 |
[MF] GO:0005230 |
None
|
GLRA1, GRIA2, GRIA4, GRIK5 |
2.23321 |
[MF] GO:0101020 |
estrogen 16-alpha-hydroxylase activity
|
CYP1A1, CYP3A4 |
2.21121 |
[MF] GO:0048037 |
cofactor binding
|
CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP3A4, HSD17B1, SRC, XDH |
2.13587 |
[MF] GO:0005158 |
None
|
IGF1R, PTPN1, SRC |
2.13292 |
[MF] GO:0016773 |
phosphotransferase activity, alcohol group as acceptor
|
AURKB, AXL, CSNK2A1, FLT3, IGF1R, KDR, MET, PIM1, PRKCA, SRC |
2.09202 |
[MF] GO:0005329 |
None
|
SLC6A2, SLC6A3 |
2.09202 |
[MF] GO:0004064 |
arylesterase activity
|
CA1, CA2 |
2.09202 |
[MF] GO:0008395 |
steroid hydroxylase activity
|
CYP19A1, CYP1A1, CYP3A4 |
2.05004 |